NTRA - Natera, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.46
|
Rev Est: $600.7M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$251.88
DETAILS
HIGH:
$285.00
LOW:
$172.00
MEDIAN:
$269.00
CONSENSUS:
$251.88
UPSIDE:
20.21%
Market Cap:
28.98B
Volume:
666,388
Avg Volume:
1,166,565
52 Week Range:
125.38-256.36
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.63
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
4,424
IPO Date:
2015-07-01
EPS (TTM):
-1.53
P/E Ratio:
-103.68
Revenue (TTM):
1.70B
Total Assets:
1.66B
Total Debt:
187.12M
Cash & Equiv:
945.59M
Rev Growth (5Y):
41.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-13.6%
Debt/Equity:
0.16
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.64 | $-0.39 | -65.9% | $592.2M | $513.5M | +15.3% |
| 2025-08-07 | $-0.74 | $-0.62 | -20.2% | $546.6M | $476.3M | +14.8% |
| 2025-05-08 | $-0.50 | $-0.64 | +21.9% | $501.8M | $446.2M | +12.5% |
| 2025-02-27 | $-0.41 | $-0.38 | -7.6% | $476.1M | $435.6M | +9.3% |
| 2024-11-12 | $-0.26 | $-0.57 | +54.4% | $439.8M | $361.4M | +21.7% |
| 2024-08-08 | $-0.30 | $-0.69 | +56.5% | $413.4M | $343.0M | +20.5% |
| 2024-05-09 | $-0.56 | $-0.71 | +21.1% | $367.7M | $316.3M | +16.3% |
| 2024-02-28 | $-0.64 | $-0.73 | +12.3% | $311.1M | $300.0M | +3.7% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.70B | 1.08B | 820.22M | 625.49M | 391.00M | 302.33M | 257.65M | 210.94M | 217.07M | 190.35M | 159.29M | 55.17M |
| Net Income | (190.43M) | (434.80M) | (547.80M) | (471.72M) | (229.74M) | (124.83M) | (128.15M) | (136.31M) | (95.77M) | (70.28M) | (5.15M) | (37.11M) |
| EPS | -1.53 | -3.78 | -5.57 | -5.21 | -2.84 | -1.79 | -2.22 | -2.56 | -1.86 | -1.47 | -0.14 | -1.01 |
| Total Assets | 1.66B | 1.44B | 1.39B | 1.24B | 932.15M | 582.66M | 268.17M | 214.61M | 210.68M | 265.24M | 123.62M | 59.72M |
| Total Debt | 187.12M | 441.99M | 446.22M | 397.23M | 281.09M | 155.81M | 123.51M | 123.18M | 49.62M | 42.09M | 26.81M | 24.31M |
| Cash & Equivalents | 945.59M | 642.10M | 466.09M | 84.39M | 48.67M | 61.93M | 46.41M | 12.62M | 15.26M | 28.95M | 87.18M | 30.50M |
| Operating Cash Flow | 135.66M | (246.96M) | (431.50M) | (335.24M) | (182.51M) | (63.44M) | (70.58M) | (96.79M) | (73.90M) | (37.83M) | 10.49M | (24.13M) |
| Free Cash Flow | 69.24M | (286.15M) | (479.20M) | (376.27M) | (202.12M) | (68.41M) | (74.46M) | (106.66M) | (97.04M) | (45.68M) | 533,000 | (32.38M) |
| FCF per Share | 0.56 | -2.49 | -4.87 | -4.15 | -2.49 | -0.98 | -1.29 | -2.00 | -1.89 | -0.96 | 0.01 | -0.88 |
| Book Value | 1.20B | 765.33M | 705.74M | 653.30M | 486.24M | 278.71M | 32.16M | 25.42M | 106.48M | 184.76M | (171.34M) | (171.51M) |
| Cash & ST Investments | 968.28M | 878.98M | 898.39M | 914.28M | 737.27M | 440.99M | 153.87M | 118.87M | 146.12M | 230.53M | 87.18M | 30.50M |
| ROC Equity | -0.16 | -0.57 | -0.78 | -0.72 | -0.47 | -0.45 | -3.98 | -5.36 | -0.90 | -0.38 | N/A | N/A |